Skip to main content
Fig. 1 | World Journal of Surgical Oncology

Fig. 1

From: Short-term and long-term outcomes of indocyanine green for sentinel lymph node biopsy in early-stage breast cancer

Fig. 1

Sentinel lymph node biopsy with indocyanine green, methylene blue and technetium 99-labeled dextran. A Points a and b are the intradermal injection points around the areola of indocyanine green (ICG) and methylene blue (MB), respectively, the four red points are the subcutaneous injection points of technetium 99-labeled dextran (RI) around the tumor, and c is the body surface projection of the located sentinel lymph node (SLN) by RI. B Fluorescent-positive lymphatic vessel on the body surface can be observed live (arrow a, ICG injected point; arrow b, fluorescent-positive lymphatic vessel). C SLNs and the first SLN with blue dye. D SLNs with fluorescence and radioactivity detected by the fluorescent vascular imaging system MDM-I and RMD Navigator™ GPS (Gamma Positioning System)

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us